<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399178</url>
  </required_header>
  <id_info>
    <org_study_id>2006-003233-32</org_study_id>
    <secondary_id>BUP4009</secondary_id>
    <nct_id>NCT00399178</nct_id>
  </id_info>
  <brief_title>A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol</brief_title>
  <official_title>A Randomised Open Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of Norspan Versus Tiparol Retard in Subjects With Chronic Moderate to Severe OA Pain of the Hip and/or Knee.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma AB</source>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of Norspan versus Tiperol Retard among OA patients who&#xD;
      are sub-optimally treated with current analgesic. Those patients may benefit from treatment&#xD;
      with a long lasting analgesic.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Box Scale 11 pain scores for pain on average during the last week then mean change from base line to completion. BS11 is recorded daily by the patients in a diary.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue medication recorded daily by patients. Sleep disturbance and quality of sleep. Patients global assessment of pain relief, investigators global assessment of pain relief, patients preference, WOMAC OA index, EuroQoL EQ-5D.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Osteoarthritis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transdermal delivery system</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  OA diagnosis&#xD;
&#xD;
          -  BS11 greater than or equal to 4 at base line&#xD;
&#xD;
          -  Not adequately pain relieved with 4,000 mg paracetamol daily&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Treated with high potent opioids for their OA pain&#xD;
&#xD;
          -  Treated with a regular dose for greater than one week of Tramadol, Codeine or&#xD;
             dextropropoxifene during the last three months&#xD;
&#xD;
          -  Other chronic conditions requiring frequent analgesic therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>M Karlsson, Med</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Dr Mats Karlsson</name>
      <address>
        <city>Falkoping</city>
        <state>Parkgatan 6C</state>
        <zip>521 43</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2006</verification_date>
  <study_first_submitted>November 10, 2006</study_first_submitted>
  <study_first_submitted_qc>November 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2006</study_first_posted>
  <last_update_submitted>August 16, 2007</last_update_submitted>
  <last_update_submitted_qc>August 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2007</last_update_posted>
  <keyword>Osteoarthritis</keyword>
  <keyword>Norspan versus Tramadol</keyword>
  <keyword>Randomised</keyword>
  <keyword>Efficacy and safety</keyword>
  <keyword>OA pain of the hip and/or knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

